Patents by Inventor Ashok C. Bajji

Ashok C. Bajji has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Purine-core inhibitors of HSP90 and their use in treating cancer
    Patent number: 8476285
    Abstract: The invention relates to compounds of Formulae I-III: and therapeutic uses thereof, wherein A is chosen from a substituted or unsubstituted aryl, heteroaryl, heterocyclic, or carbocyclic group; B is chosen from a substituted or unsubstituted piperidine, homopiperidine, piperazine, pyrrolidine or azetidine group; R1 is chosen from hydro, alkyl, aryl, heteroaryl, amino, or halo; and L1, L2, are as defined herein.
    Type: Grant
    Filed: June 30, 2009
    Date of Patent: July 2, 2013
    Assignee: Myrexis, Inc.
    Inventors: Ashok C. Bajji, Se-Ho Kim, Benjamin Markovitz, Richard Trovato, Rajendra Tangallapally, Mark B. Anderson, Daniel Wettstein, Mark Shenderovich, John A. Vanecko
  • Therapeutic Compounds and Their Use in Treating Diseases and Disorders
    Publication number: 20100292255
    Abstract: The invention provides novel therapeutic compounds, pharmaceutical compositions comprising these compounds, and methods for using these compounds and compositions to treat diseases and disorders, such as cancer.
    Type: Application
    Filed: May 14, 2010
    Publication date: November 18, 2010
    Applicant: Myriad Pharmaceuticals, Inc.
    Inventors: Ashok C. Bajji, Se-Ho Kim, Rajendra Tangallapally, Benjamin J. Markovitz, Richard Trovato, Mark B. Anderson, Daniel A. Wettstein, Mark D. Shenderovich
  • THERAPEUTIC COMPOUNDS AND THEIR USE IN CANCER
    Publication number: 20100016586
    Abstract: The invention relates to compounds of Formulae I-III and their therapeutic uses.
    Type: Application
    Filed: June 30, 2009
    Publication date: January 21, 2010
    Applicant: Myriad Genetics, Incorporated
    Inventors: ASHOK C. BAJJI, Se-Ho Kim, Benjamin Markovitz, Richard Trovato, Rajendra Tangallapally, Mark B. Anderson, Daniel Wettstein, Mark Shenderovich, John A. Vanecko
  • Therapeutic compounds and their use in cancer
    Patent number: 7595401
    Abstract: The invention relates to compounds of Formula I and their therapeutic uses, wherein substituent A is chosen from a substituted or unsubstituted aryl, heteroaryl, heterocyclic, or carboxylic group, B is chosen from a substituted or unsubstituted piperidine, homopiperidine, piperazine, pyrrolidine or azetidine group, R1 is chosen from hydro, alkyl, aryl, heteroaryl amino and halo, and L1 and L2 are as defined in the specification.
    Type: Grant
    Filed: May 14, 2007
    Date of Patent: September 29, 2009
    Assignee: Myriad Pharmaceuticals, Inc.
    Inventors: Ashok C. Bajji, Se-Ho Kim, Benjamin Markovitz, Richard Trovato, Rajendra Tangallapally, Mark B. Anderson, Daniel Wettstein, Mark Shenderovich, John A. Vanecko
  • Compounds, compositions, and methods employing same
    Patent number: 7547804
    Abstract: Compounds and pharmaceutical compositions containing the same are provided, which are useful in therapeutic treatment or prevention of various diseases.
    Type: Grant
    Filed: January 18, 2005
    Date of Patent: June 16, 2009
    Assignee: Myriad Genetics, Inc.
    Inventors: Ashok C. Bajji, Esther Arranz, Jayasree M. Srinivasan, Eric Delmar, Rachel Slade, Jon Adam Willardsen